Neola Medical EN
  • Lung Monitoring
  • The technology
  • Our Studies
  • About Us
  • Career
  • Investors
    • To invest in Neola Medical
    • Stock information
    • Annual General Meetings
    • Corporate governance
    • Certified Adviser
    • Rights Issue 2022
    • Investor Relations
    • IPO 2020
    • Presentations
    • Press releases
    • Reports and Financial Calendar
    • Warrants of series TO1
  • News
    • Press releases
    • Articles and posts
  • SE
Select Page

Articles and posts

U

Select

  • All
  • News
CEO Hanna Sjöström comments Q2 report 2023 in new article by BioStock

CEO Hanna Sjöström comments Q2 report 2023 in new article by BioStock

August 17, 2023 | News
Neola Medical AB appoints ABG Sundal Collier as liquidity provider

Neola Medical AB appoints ABG Sundal Collier as liquidity provider

August 17, 2023 | News, Regulatory
CEO and CFO presents Q2 2023

CEO and CFO presents Q2 2023

August 16, 2023 | News, Presentations
Neola Medical Q2 report 2023 – Intensified work in the market preparations before launch in the U.S.

Neola Medical Q2 report 2023 – Intensified work in the market preparations before launch in the U.S.

August 15, 2023 | News, Regulatory
Neola Medicals trademark has been registered in the U.S.

Neola Medicals trademark has been registered in the U.S.

August 8, 2023 | News, Non regulatory
Neola Medical invites to presentation of the Q2-report 2023

Neola Medical invites to presentation of the Q2-report 2023

August 7, 2023 | News, Non regulatory
Neola Medical’s CEO tells more about the latest news in the investor letter for summer 2023

Neola Medical’s CEO tells more about the latest news in the investor letter for summer 2023

July 10, 2023 | News, Non regulatory
CEO Hanna Sjöström interviewed in Direkt Studios about the work before the U.S. launch

CEO Hanna Sjöström interviewed in Direkt Studios about the work before the U.S. launch

July 5, 2023 | News
CEO Hanna Sjöström in new interview with BioStock about the market preparation work in the U.S.

CEO Hanna Sjöström in new interview with BioStock about the market preparation work in the U.S.

June 29, 2023 | News
Neola Medical initiates market preparation work in the U.S. with an office in Palo Alto, Silicon Valley

Neola Medical initiates market preparation work in the U.S. with an office in Palo Alto, Silicon Valley

June 14, 2023 | News, Non regulatory
Presentation about Neola Medical at ABGSC Life Science Summit Seminar in May 2023

Presentation about Neola Medical at ABGSC Life Science Summit Seminar in May 2023

June 7, 2023 | News, Presentations
CEO Hanna Sjöström comments Q1 report 2023 in new article by BioStock

CEO Hanna Sjöström comments Q1 report 2023 in new article by BioStock

May 22, 2023 | News
  • #
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • $

For Investors

We are on a journey to revolutionize neonatal intensive care
Learn more about investing in Neola Medical

Join our journey
About Neola Medical

Neola Medical AB (publ) is revolutionizing neonatal intensive care with Neola®, a medical device that can offer continuous lung monitoring and real-time alerts of life-threatening complications using a cutting-edge technology that measures lung volume changes and oxygen gas concentration. Neola® has the potential to provide better care, fewer days in intensive care and healthier lives for preterm born infants. Founded in 2016 and headquartered in Lund, Sweden, Neola Medical is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to global health care.

Sweden, HQ

Neola Medical AB
Scheelevägen 27
223 63 Lund
info@neolamedical.com

USA

Neola Medical AB
Nordic Innovation House
470 Ramona Street PMB
Palo Alto CA 94301-1707
info@neolamedical.com